• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of Parkinson's disease causing substances

Research Project

Project/Area Number 10470495
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field 医薬分子機能学
Research InstitutionHiroshima University

Principal Investigator

OHTA Shigeru  Hiroshima University, Faculty of Medicine, Professor, 医学部, 教授 (60160503)

Co-Investigator(Kenkyū-buntansha) SUGIHARA Kazumi  Hiroshima University, Faculty of Medicine, Research Associate, 医学部, 教務員 (20271067)
KITAMURA Shigeyuki  Hiroshima University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (40136057)
YOSHIHARA Shinichi  Hiroshima University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (00037607)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 1999: ¥1,500,000 (Direct Cost: ¥1,500,000)
KeywordsParkinson's disease / tetrahydroisoquinoline / Parkinson's disease cpreventing substance / dopaminergic neuron / Parkinson's disease causing substance / cell culture
Research Abstract

1, 2, 3, 4-Tetrahydroisoqpinoline (TIQ) derivatives, which chemically resemble MPTP, exist in mammals and have been proposed as candidates for endogenous parkinsonogenic compounds.
It was recently reported 1-benzyl-1, 2, 3, 4-tetrahydroisoqpinoline (1BnTIQ) is present in human cerebrospinal fluid and mouse brain, and proposed that 1BnTIQ is biosynthesized from 2-phenylethylamine and phenylacetaldehyde which is a metabolite of 2-pherrylethylamine generated by monoanrine oxidase-type B. The 1BnTIQ content in cerebrospinal fluid of patients with PD is higher than that of patients with other neurological diseases. Further, repeated administration of this compound induced parkinsonism in the monkey and mouse. 1BnTIQ inhibited dopamine uptake through dopamine transporter (DAT) expressed in HEK293 cells, suggesting that 1BnTIQ is uptaken through DAT as 1-methyl-4-phenylpyridinium ion, which is an active metabolite of dopaminergic neurotoxin, MPTP. We also reported that various tetrahydroisoquinoline derivatives including 1BnTIQ inhibited mitochondrial respiration and the electron transfer complexes.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (34 results)

All Other

All Publications (34 results)

  • [Publications] H.Kawai: "Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives:uptake by dopamine transporter and activity to induce parkinsonism"J.Neurochem.. 70. 745-751 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y.Kotake: "Deprenyl decreases an endogenous parkinsonisum-inducing compound,1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice in vivo and in vitro studies"Brain Res.. 787. 341-343 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T.Okada: "Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine trnsporter expressed in HEK293 cells"Neurisci.Res.. 30. 87-90 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K.Matsubara: "Sturactural significance of azaheterocyclic amines related to Parkinson's disease from dopamine transporter"Eur.J.Pharmacol.. 348. 77-84 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] N.Morikawa: "Effects of various tetrahydroisoquinoline derevative on mitochondrial respiration and the electron transfer complexes"J.Neural Transm.. 105. 677-688 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T.Yamalawa: "Biosynthesis of a parkinsonism-preventing substance,1-methy-1,2,3,4-tetrahydroisoquinoline,is inhibited by parkinsonism-inducing compunds"Neurosci. lett.. 259. 157-167 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y.Kotake: "Progress in Alzheimuer's and Parkinson'S deseases"Plenum Press. 745 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] S.Ohta.: "Neuroroxic factors Parkinson's disease and related disorders"Kluwer Academic/Plenum Publishers(in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Kawai, Y, Makino, Hirobe, S. Ohta: "Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives : uptake by dopamine transporter and activity to induce parkmsonism."J. Neurochem.. 70. 745-751 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y. Kotake, Y. Tasaki, M. Hirobe, S. Ohta: "Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice' in vivo and in vitro studies."Brain Res.. 787. 341-343 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T. Okada, K. Sato, S. Shimada, Y. Kotake, H. Kawai, S. Ohta, M. Tohyama, T. Nishimura: "Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine transporter expressed in HEK293 cells."Neurosci. Res.. 30. 87-90 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Matsubara, T. Senda, T. Uezono, S. Fukushima, S. Ohta, K. Igarashi, M. Naoi. Y. Yamashita, K. Ohtaki, N. Hayase, S. Akutsu, K. Kimura: "Sturactural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter."Eur. J. Pharmacol.. 348. 77-84 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] N. Morikawa, M. Naoi, W. Maruyama, S. Ohta, Y. Kotake, H. Kawai, T. Niwa, P. Dostert, Y. Mizuno: "Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes."J. Neural Transm.. 105. 677-688 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] S. Yoshihara. S. Ohta: "Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dehydropyridinium(MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone."Arch. Biochem. Biophys.. 360. 93-98 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T. Yamakawa, S. Ohta: "Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction."Neurosci. Lett.. 359. 157-160 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Kawai, Y. Kotake, Y. Makino, M. Hirobe. S. Ohta: "Dopaminergic activity of endogenous 1BnTIQ derivatives."Neurochem. Res.. 24. 127 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T. Yamakawa, S. Ohta: "Biosynthesis of 1-methyl-1,2,3,4-tetraHydroisoquinoline, an endogenous parkinsonism-preventing substance in the brain."Neurochem. Res.. 24. 129 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] T. Yamakawa, Y. Kotake, M. Fujitani, H. Shintani, Y. Makino, S. Ohta: "Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain."Neurosci. Lett.. 276. 68-70 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Igarashi, Y, Sugiyama, F. Kasuya, K. Saiki, T. Yamakawa, S. Ohta: "Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring."J. Chromatogr. B. 731. 53-58 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] S. Yoshihara, K. Harada, S. Ohta: "Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Perfused Rat Liver : Involvement of Hepatic Aldehyde Oxidase as a Detoxification Enzyme."Drug Metab. Dispos.. (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H.Kawai: "Novel endogenous 1,2,3,4,-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism."J.Neurochem.. 70. 745-751 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Y.Kotake: "Deprenyl decreases an endogenous parkinsonism-inducing componud, 1-benzyl-1,2,3,4-tetrahydroisquinoline in mice' in vivo and in vitro studies."Brain Res.. 787. 341-343 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] T.Okada: "Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine trnsporter expressed in HEK293 cells."Neurosci.Res.. 30. 87-90 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] K.Matsubara: "Sturactural significance of azaheterocycclic amines related to Rarkinson's disease for dopamine transporter."Eur.J.Pharmacol.. 348. 77-84 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] N.Morikawa: "Effects of various tetrahydroisquinoline derivatives on mitochondrial respiration and the electron teansfer complexes."J.Neural Transm.. 105. 677-688 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] T.Yamakawa: "Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4,-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds"Neurosci.Lctt.. 259. 157-160 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Y.Kotake: "Progress in Alzheimer'sand parkinson's diseases"Plenum Press. 745 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] S.Ohta.: "Neurotoxic factors in Parkinson's disease and related disorders."Kluwer Academic/Plenum Publishers.(in press).. (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] H.Kawai: "Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives:uptake by dopamine transporter and activity to induce parkinsonism." J.Neurochem.70. 745-751 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Y.Kotake: "Deprenyl decreases an endogenous parkinsonism-inducing compound,1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice'in vivo and in vitro studies." Brain Res.787. 341-343 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] T.Okada: "Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine trnsporter expressed in HEK293 cells." Neurosci.Res.30. 87-90 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] K.Matsubara: "Sturactural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter." Eur.J.Pharmacol.348. 77-84 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] N.Morikawa: "Effects of various tertahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes." J.Neural Transm.105. 677-688 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] T.Yamakawa: "Biosynthesis of a parkinsonism-preventing substance,1-methyl-1,2,3,4-tetrahydroisoquinoline,is inhibited by parkinsonism-inducing compounds" Neurosci.Lett.259. 157-160 (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi